deoxynivalenol has been researched along with Skin Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Asthana, S; Chaturvedi, S; Dewangan, J; Divakar, A; Kumar, S; Mishra, S; Rath, SK; Sharma, D; Srivastava, S; Wahajuddin, M | 1 |
| Chaudhari, BP; Das, M; Dwivedi, PD; Mishra, S; Pandey, HP; Tewari, P | 1 |
| Eppley, RM; Hines, FA; Lambert, LA | 1 |
3 other study(ies) available for deoxynivalenol and Skin Neoplasms
| Article | Year |
|---|---|
N-acetyl-cysteine in combination with celecoxib inhibits Deoxynivalenol induced skin tumor initiation via induction of autophagic pathways in swiss mice.
Topics: Acetylcysteine; Animals; Autophagy; Celecoxib; Mice; Skin Neoplasms; Trichothecenes | 2020 |
Deoxynivalenol induced mouse skin tumor initiation: Elucidation of molecular mechanisms in human HaCaT keratinocytes.
Topics: Animals; Apoptosis; Carcinogens; Cell Cycle Proteins; Cell Line; DNA Damage; Food Contamination; Gene Expression Regulation, Neoplastic; Humans; Keratinocytes; MAP Kinase Signaling System; Mice; Reactive Oxygen Species; Skin Neoplasms; Trichothecenes | 2016 |
Lack of initiation and promotion potential of deoxynivalenol for skin tumorigenesis in Sencar mice.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Administration, Topical; Animals; Body Weight; Carcinoma, Squamous Cell; Data Interpretation, Statistical; Female; Hyperplasia; Mice; Organ Size; Papilloma; Random Allocation; Skin; Skin Neoplasms; Spleen; Tetradecanoylphorbol Acetate; Trichothecenes | 1995 |